Swedish Orphan Biovitrum AB (publ) (OM:SOBI) entered into a definitive agreement and plan of merger to acquire CTI BioPharma Corp. (NasdaqCM:CTIC) from a group of shareholders for $1.2 billion.

Swedish Orphan Biovitrum AB entered into a definitive agreement and plan of merger to acquire CTI BioPharma Corp. from a group of shareholders for $1.2 billion on May 10, 2023. Under the terms of... |

Related Keywords

Stockholm ,Sweden ,Scott Shean ,Katherine Ashley ,Graham Robinson ,America Europe ,Dunn Crutcher ,Mannheimer Swartling ,Leah Sauter ,Meagher Flom ,Centerview Partners ,Latham Watkins ,Danske Bank ,Health Partners ,Biopharma Corp ,Gibson ,Swedish Orphan Biovitrum ,Effective Time ,Hart Scott Rodino Antitrust Improvements ,Cti Biopharma Corp Stock Exchange ,News ,Information ,Press Release ,Swedish ,Orphan ,Iovitrum ,Tb ,Ntered ,Into ,Efinitive ,Agreement ,End ,Plan ,F ,Berger ,O ,Cquire ,Ti ,Iopharma ,Rom ,Group ,Shareholders ,Or ,Billion ,N ,Bay ,Under ,The ,Erms Ctic Us12648l6011 ,